Zinc toxicity: Difference between revisions

No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 27: Line 27:
**Acute lung injury
**Acute lung injury
**[[Acute Respiratory Distress Syndrome]]
**[[Acute Respiratory Distress Syndrome]]
**Metal fume fever
**[[Metal fume fever]]


===Chronic===
===Chronic===
Line 46: Line 46:
*Ceruloplasmin level
*Ceruloplasmin level
*Abdominal films to assess for foreign bodies
*Abdominal films to assess for foreign bodies
*MRI
*[[brain MRI|MRI]]
**Will show increase T<sub>2</sub> signal in the dorsal columns of the cervical cord
**Will show increase T<sub>2</sub> signal in the dorsal columns of the cervical cord


Line 52: Line 52:
*Oral toxicity
*Oral toxicity
**Supportive Care
**Supportive Care
***Hydration
***[[IVF|Hydration]]
***[[H2 blocker|H<sub>2</sub> receptor antagonists]] or [[PPI]]
***[[H2 blocker|H<sub>2</sub> receptor antagonists]] or [[PPI]]
***[[Antiemetics]]
***[[Antiemetics]]
**Consider whole bowel irrigation
**Consider [[whole bowel irrigation]]
*Inhalation
*Inhalation
**Supportive care
**Supportive care
***[[Oxygen therapy]]
***[[Oxygen therapy]]
***[[Bronchodilators]]
***[[Bronchodilators]]
**Metal fume fever
**[[Metal fume fever]]
***Usually self limiting
***Usually self limiting
***CXR usually normal
***[[CXR]] usually normal
*Chelation
*Chelation
**Limited data on use, and data present is based off of case reports and treatment for lead toxicity <ref>Majlesi, N. Zinc. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1342</ref>
**Limited data on use, and data present is based off of case reports and treatment for lead toxicity <ref>Majlesi, N. Zinc. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1342</ref>
Line 81: Line 81:
==References==
==References==
<references/>
<references/>
Majlesi, N. Zinc. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1339-1344


[[Category:Toxicology]]
[[Category:Toxicology]]

Latest revision as of 18:26, 28 September 2021

Background

  • Transition metal
  • Essential nutrient
  • Exposure from diet, medicinal uses, nutritional supplements, and occupational exposures
    • Multiple case reports of zinc toxicity related to ingestion of United States pennies which contain 97.5% zinc

Toxicokinetics

  • Absorbed primarily in the jejunum
  • Excreted via the GI tract with minimal amounts excreted in the urine
  • Accumulates in erythrocytes
    • Whole blood concentrations are 6-7x higher than in the serum
  • Inverse relationship with copper
    • Excess zinc absorption will cause a counterregulatory response resulting in copper elimination

Clinical Features

Acute

Chronic

Differential Diagnosis

Evaluation

  • BMP
  • CBC
  • Copper level
  • Ceruloplasmin level
  • Abdominal films to assess for foreign bodies
  • MRI
    • Will show increase T2 signal in the dorsal columns of the cervical cord

Management

  • Oral toxicity
  • Inhalation
  • Chelation
    • Limited data on use, and data present is based off of case reports and treatment for lead toxicity [1]
    • Consider in patients with hemodynamic compromise
    • CaNa2EDTA, British antilewisite, DTPA were all successfully used in case reports
    • 1000mg/m2/d IV CaNa2EDTA every 6 hours
      • Based on a successful case report, but should be given in conjunction with toxicology or poison control center
  • Dermal Exposures
    • Do not use water in metallic zinc exposures
      • Concern metal will ignite
    • Remove zinc with forceps and apply mineral oil to affected skin
  • Copper replacement
    • Oral copper alone shown to improve hematopoietic effects and prevent further neurological deterioration [2]

Disposition

References

  1. Majlesi, N. Zinc. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1342
  2. Rowin J, Lewis SL. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry. 2005;76:750-751.